P. Burgisser et al., Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1, J ACQ IMM D, 23(2), 2000, pp. 138-144
Five methods for the assessment of plasma viral load (VL) were evaluated in
103 seropositive patients infected with various subtypes of HIV-1. The met
hods included three RNA-based assays (Amplicor Monitor 1.5, Quantiplex vers
ion 2.0, NucliSens), one ultrasensitive reverse transcriptase (PERT) assay
and one "boosted" p24 antigen (Ag) enzyme immunoassay (EIA). Subtyping was
based on sequencing in env. The sensitivities were, in decreasing order, Am
plicor > PERT > p24 Ag > NucliSens > Quantiplex. The low sensitivity of Nuc
liSens was related to the missing of several non-B (A, E, F, G) or recombin
ant strains, whereas that of Quantiplex did not depend on subtype. In the 1
group O sample and 4 group M samples, only PERT assay or p24Ag EIA produce
d a positive result. In the quantitative range, correlation was best betwee
n Amplicor and Quantiplex (r = 0.8848), fair between Amplicor and NucliSens
(r = 0.7064) or PERT assay (r = 0.7266), lowest between Amplicor and p24Ag
EIA (r = 0.3989). Amplicor underestimated VL in 1 subtype E sample. Thus,
Amplicor performed best in terms of sensitivity (compared with all other as
says) and accuracy (compared with NucliSens, PERT assay, and p24Ag) for non
-B subtypes in group M samples. PERT assay appears useful for VL assessment
in infections by group O or other highly divergent viruses.